CTRI Number |
CTRI/2017/05/008583 [Registered on: 17/05/2017] Trial Registered Retrospectively |
Last Modified On: |
18/05/2017 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Siddha |
Study Design |
Single Arm Study |
Public Title of Study
|
Clinical evaluation of siddha drug Seenthil choornam (internal) and Puzhuvettuthylam (external) in the treatment of Alopecia areata in children. |
Scientific Title of Study
Modification(s)
|
Clinical evaluation of siddha drug Seenthil choornam(internal) and Puzhuvettu thylam(external) in the treatment of Puzhuvettu (alopecia areata) in children on open clinical study |
Trial Acronym |
Alopecia |
Secondary IDs if Any
|
Secondary ID |
Identifier |
Nil |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr M Bakkiyadevi |
Designation |
PG Scholar |
Affiliation |
National Institute of Siddha |
Address |
Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium. Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium. Kancheepuram TAMIL NADU 600047 India |
Phone |
9994627411 |
Fax |
|
Email |
bakkiyadevim@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr M Meenakshi sundaram |
Designation |
Associate professor Head of the Dept i/c |
Affiliation |
National Institute of Siddha |
Address |
Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium. Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium. Kancheepuram TAMIL NADU 600047 India |
Phone |
9444214582 |
Fax |
04422381314 |
Email |
mmssiddha@rediffmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr M Meenakshi sundaram |
Designation |
Associate professor Head of the Dept i/c |
Affiliation |
National Institute of Siddha |
Address |
Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium. Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium.
TAMIL NADU 600047 India |
Phone |
9444214582 |
Fax |
04422381314 |
Email |
mmssiddha@rediffmail.com |
|
Source of Monetary or Material Support
|
Ayothidoss pandithar hospital National institute of siddha Tambaram sanatorium chennai-47 |
|
Primary Sponsor
|
Name |
Ayothidoss pandithar hospital |
Address |
Natoinal institute of siddha Tambaram sanatorium. |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr M Bakkiyadevi |
Ayothidoss Pandithar Hospital, National Institute of Siddha |
OPD NO 9 and IPD,Department of Kuzhandhai maruthuvam, National institute of siddha, tambaram sanatorium Kancheepuram TAMIL NADU |
9994627411
bakkiyadevim@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional ethics committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Alopecia areata, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
nil |
nil |
Intervention |
Seenthil choornam(internal) and Puzhuvettu thylam (external) |
350-700 mg bd with sugar for 45 days and Puzhuvettu thylam
for external apply |
|
Inclusion Criteria
|
Age From |
6.00 Year(s) |
Age To |
12.00 Year(s) |
Gender |
Both |
Details |
1)Scattered long hair within the bald area
2)Unscarring
3)The area of hair loss may tingle or be painful
4)Affecting region is small
5)Hair loss present on the patches
6)Patients who are satisfying minimum of 3-4 above mentioned symptoms
7)Patient willing to undergo routine blood investigation. |
|
ExclusionCriteria |
Details |
1) Loss of hair in the shape of a way at the circumference of the head
2) Scarring alopecia
3)In case of severe hair loss
4) Alopecia tottalis
5) Vitiligo
6)Atopic dermatitis
7) Thyroid disease
8)Down syndrome |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Case Record Numbers |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Primary outcome is mainly assessed by severity of Alopecia tool score(SALT SCORE) |
45 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
Secondary outcome is assessed by comparing the following parameters before and after the treatment
1) Improvement in clinical symptoms
2) Any changes in before and after photographs.
|
45 days |
|
Target Sample Size
|
Total Sample Size="10" Sample Size from India="10"
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
02/01/2017 |
Date of Study Completion (India) |
Date Missing |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
None yet |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
It is the single non-randomized,open label trial to determine the efficacy of Seenthil choornam (internal) and Puzhuvettu thylam (external) prepared from herbal constitutents in the patients with Puzhuvettu (Alopecia areata). In this trial 10 patients will be recruited and the trial drug will be administered 350mg - 700mg Twice a day with sugar for a period of 45 days. During the trial period if any AE/SAE/SUSAR will be noticed and refered to pharmacovigilance department in NIS and further management will also be given in NIS OPD/IPD. The entire trial will be monitored by the research monitoring committee of NIS. During this trial all the safety efficacy parameters will be recorded in the CRF. After completion of the trial all the study related data will be analysed statistically. The outcome of this trial will be published in India Journal of Medical research. |